Miso

Japan's ancient fermented soybean paste — rich in probiotics, isoflavones, and bioactive compounds with evidence for gut health, cardiovascular support, and cancer prevention

Miso is a fermented paste made from soybeans, salt, and a mold culture called koji (Aspergillus oryzae). It has been central to Japanese cuisine for over a thousand years, and decades of research have produced something unexpected: despite being a salty food, habitual miso consumption is not associated with higher blood pressure — and may actually lower it [1][3]. Beyond the sodium paradox, miso delivers probiotics, bioavailable isoflavones, and a complex of fermentation-derived compounds linked to reduced cancer risk and improved immune regulation [4][5].

What Miso Is and How It Is Made

Miso is produced by fermenting a mixture of cooked soybeans, salt, and koji — a mold that secretes enzymes to break down proteins and starches. Grains like rice or barley are often added. The fermentation period ranges from a few weeks to three years, and the duration profoundly shapes the final product.

There are three main types:

Shiro (white) miso: Short fermentation (weeks to a few months), sweet and mild. Lowest salt content.
Shinshu (yellow) miso: Medium fermentation, balanced flavor, the most widely available type.
Aka (red) miso: Long fermentation (one to three years), deeply savory, more salt and more complex bioactive compounds. Research suggests longer-fermented miso may have greater health-protective effects [6].

The fermentation process does more than preserve the soybeans — it fundamentally transforms them. Proteins are hydrolyzed into amino acids and peptides, some of which are biologically active. Isoflavones like genistein and daidzein, which are bound to sugars in raw soybeans, are released into their free aglycone forms, which are more readily absorbed by the human gut.

The Sodium Paradox

Miso contains substantial sodium — a cup of miso soup may have 600–900mg. By conventional logic, regular miso soup should raise blood pressure. It does not. Multiple studies in Japanese adults — both cross-sectional surveys and a clinical trial — find that habitual miso consumers do not have elevated blood pressure, and some actually show lower nighttime blood pressure [2][3].

The leading hypothesis, reviewed in detail by Ito (2020), is that miso suppresses sympathetic nervous system activity and modulates the renin-angiotensin system. The long-chain peptides produced during fermentation appear to have ACE-inhibiting (angiotensin-converting enzyme inhibiting) properties, similar to the mechanism of a class of blood pressure medications. These peptides may dampen the vasoconstrictive response that sodium ordinarily triggers [1].

Animal studies comparing equivalent sodium from table salt versus miso consistently show that miso does not raise blood pressure the way NaCl alone does, and longer-fermented miso shows even greater protection [6].

Gut Health and Immune Support

Miso is a live fermented food — if unpasteurized, it contains Aspergillus, Lactobacillus, and Pediococcus species. Research in mice shows that regular miso consumption stimulates calcium signaling in intestinal epithelial cells (a pathway also activated by probiotic bacteria), elevates regulatory T cells that prevent immune overactivation, and increases production of the anti-inflammatory cytokines IL-10 and IL-22 [4].

Miso-derived yeasts have also been identified with probiotic potential: strains isolated from traditional miso have demonstrated benefits in models of irritable bowel syndrome and inflammatory bowel disease, modulating the gut microbiota and reducing inflammation.

Isoflavones and Cancer Research

The isoflavones in miso — genistein and daidzein — have been studied extensively for their role in cancer prevention, particularly breast and prostate cancer. A large prospective cohort study following 21,852 Japanese women for ten years found that women with the highest miso soup intake had significantly lower breast cancer rates. The association was specific to miso soup, with isoflavone intake from all soy sources also showing a dose-dependent protective relationship [5].

Fermentation appears to matter: free aglycone isoflavones from miso are absorbed more readily than the glycoside forms in unfermented soy, producing higher blood isoflavone levels from the same amount of food. These compounds bind to estrogen receptors and may modulate estrogen signaling in a way that reduces cancer proliferation risk.

Note: The evidence is strongest for premenopausal women and traditional Asian populations with lifelong miso exposure. The effects of soy isoflavones are more complex in postmenopausal women and in people new to soy, and supplemental isoflavones behave differently from fermented food sources.

How to Use Miso

Miso soup: The classic — dissolve one to two teaspoons in warm (not boiling) water with dashi, tofu, or vegetables. Boiling destroys live cultures; add miso off the heat.
Marinades: Miso mixed with mirin, sake, and a little sesame oil makes an excellent marinade for fish, chicken, or eggplant.
Dressings: Thin miso with rice vinegar and olive oil for a savory salad dressing.
Glazes: Spread onto roasted vegetables before the last few minutes in the oven for a deeply savory crust.
Flavor base: A small amount added to soups, stews, or grain dishes adds umami depth without making the dish taste like miso.

For maximum probiotic benefit, buy unpasteurized miso from a refrigerated section and avoid cooking it above 70°C (160°F).

See our Natto page for the other traditional Japanese fermented soybean food, which offers very different compounds (nattokinase and Vitamin K2). For the broader case for fermented foods, see Living Foods.

Evidence Review

The Sodium Paradox: Blood Pressure and Cardiovascular Effects

The most scientifically striking finding about miso is the dissociation between its sodium content and its cardiovascular effects. Multiple lines of evidence support this paradox.

Ito et al. (2017) conducted a cross-sectional analysis of 2,428 Japanese adults who underwent a workplace health examination. Participants were divided into groups by miso soup consumption frequency (never/rarely, occasionally, frequently). Contrary to expectation, frequent miso soup consumers did not have higher blood pressure than infrequent consumers. Notably, high-frequency consumers had significantly lower heart rates — a finding potentially explained by sympathetic nervous system modulation [3]. Cross-sectional studies cannot establish causation, but the consistency with which sodium from miso fails to raise blood pressure, across multiple independent studies, is striking.

Kondo et al. (2019) moved to a prospective design: an 8-week clinical trial in subjects with high-normal blood pressure or stage 1 hypertension randomized to miso soup or control. Nighttime systolic blood pressure — measured by ambulatory blood pressure monitoring — declined significantly in the miso group compared to control. Daytime blood pressure was unchanged [2]. The nighttime BP finding is particularly relevant because nocturnal blood pressure is a stronger predictor of cardiovascular events than daytime readings, and non-dipping patterns (failure to lower BP at night) are associated with increased stroke and cardiac risk.

Ito's 2020 comprehensive review synthesized the mechanistic evidence: miso fermentation generates tripeptides with ACE-inhibitory activity (comparable to the mechanism of the antihypertensive drug class ACE inhibitors), and the peptides appear to modulate both the renin-angiotensin system and sympathetic nerve tone [1]. The review also notes that salty food stimulates the sympathetic nervous system, but miso appears to blunt this response — possibly because its fermented peptides counteract the pressor response that sodium ordinarily generates.

Watanabe (2013) provided key animal evidence: rats given equivalent sodium from miso paste versus NaCl showed different blood pressure outcomes, with miso failing to elevate BP at doses where NaCl did. Longer-fermented miso (180-day fermentation) was more protective than short-fermented miso. The author also reported radioprotective effects in irradiated mice given miso — an observation that has attracted interest but requires replication in humans [6].

Limitations: Most human studies are in Japanese populations with high habitual miso intake; it is unclear whether benefits transfer to people with lower baseline soy exposure. Clinical trials are short (8 weeks) and use self-reported outcomes or single-site measures. Large prospective cohort data on hard cardiovascular endpoints (myocardial infarction, stroke) are limited.

Immune Regulation

Kotake et al. (2022) conducted an animal study in which mice were fed a miso-supplemented diet for four weeks and compared with controls. Miso feeding significantly increased regulatory T cell populations in the intestinal tract, elevated anti-inflammatory cytokines IL-10 and IL-22, and activated calcium-dependent signaling pathways in intestinal epithelial cells — a pathway normally triggered by probiotic bacteria. The researchers concluded that miso exerts immunomodulatory effects that support intestinal immune tolerance, potentially reducing the risk of inflammatory conditions [4]. These findings are in mice and require human replication, but the mechanistic plausibility is strong.

Cancer Prevention: Breast Cancer and Isoflavones

Yamamoto et al. (2003) analyzed data from the Japan Public Health Center-Based Prospective Study (JPHC), following 21,852 women for approximately 10 years. After adjusting for age, BMI, family history, and other factors, women in the highest quintile of miso soup intake had a significantly lower risk of breast cancer than those in the lowest quintile (relative risk 0.60, 95% CI 0.39–0.93 for premenopausal women). Total isoflavone intake showed a dose-dependent inverse relationship with breast cancer in premenopausal women [5]. This is one of the largest prospective cohort studies on this question and benefits from detailed dietary assessment and follow-up.

Important nuance: The JPHC cohort is Japanese women with lifelong soy exposure. Japanese populations metabolize isoflavones differently than Western populations — in particular, a higher proportion of Japanese adults harbor gut bacteria that convert daidzein to equol, a metabolite with stronger estrogenic activity. Effects seen in Japanese cohorts may not fully translate to Western populations.

Watanabe (2013) also reported reduced tumor incidence in animal carcinogenesis models given miso diets versus NaCl-equivalent controls, consistent with the epidemiological finding [6].

Overall Evidence Assessment

Outcome	Evidence Type	Quality	Key Limitation
No blood pressure elevation despite sodium	Cross-sectional + RCT + animal	Moderate	Short RCT, mostly Japanese cohorts
Nighttime BP reduction	RCT	Moderate	Single 8-week trial, n not large
Immune modulation	Animal model	Low-moderate	No human replication yet
Breast cancer risk reduction	Large prospective cohort	Moderate-strong	Population-specific (Japan), observational
Cancer protection in general	Animal models	Low	Limited human evidence

Miso is best understood as a traditional food with a favorable safety profile and mounting evidence for cardiovascular and immune benefits that is distinct from the effects of equivalent sodium intake. For people without severe renal disease, regular miso consumption — one to two servings of miso soup daily — aligns with the dietary patterns of populations with exceptional longevity and cardiovascular health. The evidence does not support miso supplementation or isoflavone capsules as replacements for the whole fermented food.

References

Review of the health benefits of habitual consumption of miso soup: focus on the effects on sympathetic nerve activity, blood pressure, and heart rateIto K. Environmental Health and Preventive Medicine, 2020. PubMed 32867671 →
Long-term intake of miso soup decreases nighttime blood pressure in subjects with high-normal blood pressure or stage I hypertensionKondo H, Tomari HS, Yamakawa S, Kitagawa M, Yamada M, Itou S, Yamamoto T, Uehara Y. Hypertension Research, 2019. PubMed 31371810 →
The Effects of the Habitual Consumption of Miso Soup on the Blood Pressure and Heart Rate of Japanese Adults: A Cross-sectional Study of a Health ExaminationIto K, Miyata K, Mohri M, Origuchi H, Yamamoto H. Internal Medicine, 2017. PubMed 28049996 →
Ingestion of miso regulates immunological robustness in miceKotake K, Kumazawa T, Nakamura K, Shimizu Y, Ayabe T, Adachi T. PLoS ONE, 2022. PubMed 35061718 →
Soy, isoflavones, and breast cancer risk in JapanYamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Journal of the National Cancer Institute, 2003. PubMed 12813174 →
Beneficial Biological Effects of Miso with Reference to Radiation Injury, Cancer and HypertensionWatanabe H. Journal of Toxicologic Pathology, 2013. PubMed 23914051 →